July 18, 2019
Neurogene Initiates Natural History Study of Charcot-Marie Tooth Disease (CMT4J)
Key data now being collected to support endpoint assessment for future gene therapy clinical trial NEW YORK–(BUSINESS WIRE)–Neurogene Inc., a…
Pharmaceuticals, Biotechnology and Life Sciences
Key data now being collected to support endpoint assessment for future gene therapy clinical trial NEW YORK–(BUSINESS WIRE)–Neurogene Inc., a…
Neurogene Initiates Natural History Study of Aspartylglucosaminuria (AGU)